ING Groep NV

SEC CIK: 0001039765
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by ING Groep NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 223,124
Value: $110.8M
% of portfolio: 0.5%
Quarters held: 19; Since Q1 2021

Holdings of VRTX by ING Groep NV, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	223,124	$110.8M	0.5%	+157,699+241.0%	Added	Holders
Q1 2026	65,425	$29.2M	0.2%	−15,704−19.4%	Reduced	Holders
Q4 2025	81,129	$36.8M	0.2%	+69,140+576.7%	Added	Holders
Q3 2025	11,989	$4.70M	<0.1%	+11,989	New	Holders
Q1 2025	0	$0	0.0%	−4,784−100.0%	Sold out	Holders
Q4 2024	4,784	$1.93M	<0.1%	−48,754−91.1%	Reduced	Holders
Q3 2024	53,538	$24.9M	0.1%	−12,587−19.0%	Reduced	Holders
Q2 2024	66,125	$31.0M	0.2%	−10,918−14.2%	Reduced	Holders
Q1 2024	77,043	$32.2M	0.2%	+1,945+2.6%	Added	Holders
Q4 2023	75,098	$30.6M	0.2%	−10,060−11.8%	Reduced	Holders
Q3 2023	85,158	$29.6M	0.3%	+6,745+8.6%	Added	Holders
Q2 2023	78,413	$27.6M	0.2%	+34,115+77.0%	Added	Holders
Q1 2023	44,298	$14.0M	0.1%	+44,298	New	Holders
Q4 2022	0	$0	0.0%	−60,025−100.0%	Sold out	Holders
Q3 2022	60,025	$17.4M	0.3%	+3,056+5.4%	Added	Holders
Q2 2022	56,969	$16.1M	0.2%	+45,788+409.5%	Added	Holders
Q1 2022	11,181	$2.92M	<0.1%	−32,806−74.6%	Reduced	Holders
Q4 2021	43,987	$9.66M	0.1%	+17,641+67.0%	Added	Holders
Q3 2021	26,346	$4.78M	0.1%	+520+2.0%	Added	Holders
Q2 2021	25,826	$5.21M	0.1%	+8,614+50.0%	Added	Holders
Q1 2021	17,212	$3.70M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.